SCHEMBL33377947

SCHEMBL33377947

Clc1cc(NCCc2ccccn2)n2ncc(C3CC3)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.42
▸ MAPT P10636 4/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ IGF1R P08069 1/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ FGFR1 P11362 1/20 0.40
▸ OGA O60502 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ PGK1 P00558 1/20 0.36
▸ MKNK1 Q9BUB5 1/20 0.36
▸ APP P05067 2/20 0.35
▸ KCNN1 Q92952 1/20 0.35
▸ KCNN2 Q9H2S1 1/20 0.35
▸ KCNN3 Q9UGI6 1/20 0.35
▸ MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33378008 0.85 CDK7 (0.43) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL33377931 0.80 KDM4E (0.45) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL33378018 0.80 CHEK1 (0.45) KMT2AGSK3B
SCHEMBL30083485 0.79 KDM4E (0.47) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL30083382 0.79 GPR39 (0.48) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL30083421 0.78 KDM4E (0.40) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL30083523 0.77 KCNN3 (0.44) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL30083549 0.76 KDM4E (0.43) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL30083527 0.76 GPR39 (0.40) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL30083469 0.75 GPR39 (0.41) KDM4EMAPTNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback